蜚蠊提取物脂质体的制备、表征及其抗溃疡性结肠炎的疗效

Preparation, Characterization, and Anti-Ulcerative Colitis Efficacy of Cockroach Extract Liposomes

  • 摘要:
      目的  探索制备蜚蠊提取物长效脂质体的最佳工艺, 并评价其对溃疡性结肠炎(UC)模型小鼠的治疗效果。
      方法  采用薄膜分散法制备蜚蠊提取物长效脂质体(CE-Lip), 正交实验优化CE-Lip的处方及冻干工艺, 进行形态学表征并评价其体外释放速率, 并通过UC小鼠模型进行药效学评价。
      结果  最佳制备工艺为胆固醇-磷脂质量比1 ∶ 5, 提取物-磷脂质量比1 ∶ 4, 水化时间0.75 h, 水化体积3 mL, 水化温度30 ℃; 最佳冻干工艺为采用5%甘露醇、10%海藻糖作为混合冻干保护剂; 所制得的CE-Lip平均粒径为(276.7±5.6)nm, 呈囊泡状结构, 冻干后稳定性良好, 在体外释放速率显著低于原料药。药效学结果显示CE-Lip可以显著降低UC小鼠的DAI评分、结肠长度、CMDI评分、TNF-α表达量、HS评分, 显著升高EGF表达量、杯状细胞中的黏液素表达量。
      结论  获得简便、稳定、重现性良好的CE-Lip制备工艺。制得的CE-Lip, 大小分散均匀, 稳定性好, 具有缓释的效果, 相比于普通制剂, CE-Lip显著提高了CE对UC小鼠的治疗作用, 为CE-Lip的进一步开发研究奠定了基础。

     

    Abstract:
      OBJECTIVE  This study aimed to explore the optimal process for preparing long-acting liposomes loaded with cockroach extract (CE-Lip) and to evaluate their therapeutic efficacy against ulcerative colitis (UC).
      METHODS  The CE-Lip was prepared using a thin film dispersion method. Orthogonal experiments were conducted to optimize the formulation and freeze-drying process of CE-Lip. Morphological characterization and in vitro release rate assessment were performed. The therapeutic efficacy of CE-Lip was evaluated using a mouse model of UC.
      RESULTS  The optimal preparation process involved a cholesterol-phospholipid mass ratio of 1 ∶ 5, an extract-phospholipid mass ratio of 1 ∶ 4, hydration time of 0.75 h, hydration volume of 3 mL, and hydration temperature of 30 ℃. The optimal freeze-drying process utilized a mixture of 5% mannitol and 10% trehalose as protective agents. The resulting CE-Lip exhibited an average particle size of (276.7±5.6) nm, with a vesicular structure. The stability of CE-Lip after freeze-drying was excellent, and its in vitro release rate was significantly lower than that of the raw material. Pharmacological results demonstrated that CE-Lip significantly reduced DAI scores, colon length, CMDI scores, TNF-α expression, and HS scores in UC mice, while increasing EGF expression and mucin expression in goblet cells.
      CONCLUSION  A simple, stable, and reproducible process for preparing CE-Lip is established. The resulting CE-Lip exhibits uniform size distribution, good stability, and sustained release effects. Compared to conventional formulations, CE-Lip significantly enhanced the therapeutic effect of CE against UC in mice. This study provides a foundation for further development and research of CE-Lip.

     

/

返回文章
返回